Dechra Pharmaceuticals PLC — Board/Management Information 2014

Jan 29, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7373Y

Dechra Pharmaceuticals PLC

29 January 2014

Wednesday, 29 January 2014

Dechra Pharmaceuticals PLC

("Dechra" or the "Company")

Directorate Change

Dechra today announces that following a re-organisation of the Main Board, Ed Torr is to step down as an Executive Director and will be leaving the Company with effect from 31 January 2014.  It is Dechra's intention to enter into a Consultancy Agreement with him later in the year.

Ian Page, Chief Executive Officer of Dechra, said

"On behalf of the Board and colleagues around the business, I would like to thank Ed for the huge contribution he has made to Dechra since joining the business in 1997.  We wish him well for the future."

Enquiries:
Dechra Pharmaceuticals PLC
Ian Page, Chief Executive Officer
Zoe Goulding, Company Secretary
Tel: +44 (0) 1606 814730
TooleyStreet Communications
Fiona Tooley
Tel: +44 (0) 7785 703 523
email: fiona@tooleystreet.com

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide.  Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.

For more information please visit: www.dechra.com

Ticker: LSE Main Listing (Pharmaceuticals): DPH

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOALLFEALLITFIS